Table IV.
Patients with lung cancer N = 114 (3 missing weight data) |
|||
---|---|---|---|
Weight increased, stable or loss < 5% N = 80 (70%) | Weight loss ≥ 5% to < 10% N = 13 (12%) | Weight loss ≥ 10% N = 21 (18%) | |
Age, N (%) | |||
39–67 | 39 (74) | 5 (9) | 9 (17) |
68–89 | 41 (67) | 8 (13) | 12 (20) |
Gender, N (%) | |||
Women | 41 (67) | 8 (13) | 12 (20) |
Men | 39 (74) | 5 (9) | 9 (47) |
Tumor type, N (%) | |||
NSCLC | 63 (68) | 10 (11) | 19 (21) |
SCLC | 6 (86) | – | 1 (14) |
Other | 7 (70) | 3 (30) | – |
Unverified | 4 (80) | – | 1 (20) |
Disease stage, N (%) | |||
I-IIIA | 44 (79) | 4 (7) | 8 (14) |
IIIB-IV | 35 (61) | 9 (16) | 13 (23) |
Missing data | 1 | – | – |
Food intake previous month*, N (%) | |||
As usual or more | 68 (78) | 10 (12) | 9 (10) |
Less than usual | 12 (44.5) | 3 (11) | 12 (44.5) |
Symptoms interfering with food intake*, N (%) | |||
None | 66 (77) | 10 (11.5) | 10 (11.5) |
≥ 1 | 14 (50) | 3 (11) | 11 (39) |
TSAs*, N (%) | |||
Absent | 59 (83) | 5 (7) | 7 (10) |
Present | 21 (49) | 8 (19.5) | 14 (32.5) |
NSCLC, non small-cell lung cancer; SCLC, small-cell lung cancer; TSAs, taste and smell alterations.
*P-value < 0.05.